Neoadjuvant chemotherapy combined with bevacizumab for resectable colorectal liver metastasis with risk factors for recurrence: a multicenter real-world study

Neoadjuvant chemotherapy combined with bevacizumab for resectable colorectal liver metastasis with risk factors for recurrence: a multicenter real-world study

Background: Currently, guidelines prohibit the addition of targeted drugs in neoadjuvant chemotherapy (NAC) for initially resectable colorectal liver metastasis (CRLM). Objective: Nevertheless, efficacy data of NAC combined with bevacizumab (Bev) for initially resectable CRLM with risk factors for r...

Full description

Saved in:
Bibliographic Details
Main Authors: Yizhen Chen, Yuanyuan Zheng, Jia Wu, Rong Ye, Hangdong Jia, Zhenyuan Zhou, Weijie Chen, Linwei Xu, Yuhua Zhang, Ming Zheng
Format: Article
Language:English
Published: SAGE Publishing 2025-03-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359251328457
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items